A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases.
Docherty CA, Fernando AJ, Rosli S, Lam M, Dolle RE, Navia MA, Farquhar R, La France D, Tate MD, Murphy CK, Rossi AG, Mansell A.
Docherty CA, et al.
Clin Transl Immunology. 2023 Jun 22;12(6):e1455. doi: 10.1002/cti2.1455. eCollection 2023.
Clin Transl Immunology. 2023.
PMID: 37360982
Free PMC article.